home / stock / gmed / gmed articles
AUDUBON, Pa., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its...
AUDUBON, Pa., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced t...
AUDUBON, Pa., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced p...
Stifel analyst Mathew Blackman upgraded Globus Medical, Inc. (NYSE: GMED) to Buy from Hold, lowering the price target to $61 fr...
—Creates leading global musculoskeletal company——Robust portfolio well-positioned for long-term growth and continued innovation— AUDUBON, ...
News, Short Squeeze, Breakout and More Instantly...
Globus Medical Inc. Class A Company Name:
GMED Stock Symbol:
NYSE Market:
Globus Medical Inc. Class A Website:
AUDUBON, Pa., July 17, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced it recently received 510(k) clearance by the U.S. Food and Drug Administration (FDA) for ExcelsiusFlex™ with Total Knee Arthroplasty (TKA) applica...
2024-05-20 06:00:04 ET Matt O'Brien from Piper Sandler issued a price target of $80.00 for GMED on 2024-05-20 04:50:00. The adjusted price target was set to $80.00. At the time of the announcement, GMED was trading at $64.4. The overall price target consensus is at $78.6...
2024-05-11 10:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...